Examkin

Question

Difficulty: HardCardiovascular System

A 67-year-old retired factory worker is evaluated in the outpatient clinic due to progressive bilateral lower extremity swelling, abdominal fullness, and exertional breathlessness over the past 3 months. He has a 45-pack-year smoking history and a five-year history of severe chronic obstructive pulmonary disease (COPD). His current daily medications include an inhaled corticosteroid, a long-acting muscarinic antagonist, and a long-acting beta-agonist. Today, his blood pressure is 128/78 mmHg, pulse is 88/min, and oxygen saturation is 87% on room air. Physical examination reveals a barrel-shaped chest. Jugular venous distension is prominent at 11 cm H2O. Lung fields are hyperresonant to percussion with globally diminished breath sounds but no crackles. Cardiac auscultation reveals a palpable right ventricular heave and a distinctly loud pulmonic component of the second heart sound (P2), with no apical murmurs or left-sided gallops. Abdominal palpation demonstrates hepatomegaly and a positive hepatojugular reflux. A recent transthoracic echocardiogram confirms severe right ventricular dilation and right ventricular hypertrophy, alongside a normal left ventricular ejection fraction of 62%. Which of the following interventions is most likely to prolong this patient's survival?

  1. Continuous long-term supplemental oxygen therapyAnswer
  2. B
    Initiation of a beta-blocker and an angiotensin-converting enzyme (ACE) inhibitor
  3. C
    Daily administration of broad-spectrum oral antibiotics
  4. D
    Initiation of oral amlodipine to induce pulmonary vasodilation
  5. E
    Routine calculation of acid-base compensation via weekly arterial blood gases

Answer

Continuous long-term supplemental oxygen therapy
The correct answer is continuous long-term supplemental oxygen therapy. This patient presents with classic signs of cor pulmonale (right-sided heart failure secondary to chronic pulmonary disease). His severe COPD has caused chronic hypoxia, leading to continuous hypoxic pulmonary vasoconstriction, secondary pulmonary hypertension, and eventual right ventricular hypertrophy and dilation. In patients with COPD who have severe resting hypoxemia (defined as an oxygen saturation <= 88% or PaO2 <= 55 mmHg), long-term supplemental oxygen therapy (used for at least 15 hours per day) is one of the only interventions that has been definitively proven to prolong survival. It works by alleviating the hypoxic pulmonary vasoconstriction, thereby reducing right ventricular afterload and delaying the progression of cor pulmonale.

Step-by-Step Solution

1
Analyze the patient's presentation and physical exam findings.
The patient has signs of isolated right-sided heart failure (jugular venous distension, right ventricular heave, loud P2, hepatomegaly) with clear lungs and normal left ventricular function on echocardiography.
This establishes the diagnosis of cor pulmonale, secondary to his known severe COPD.
2
Identify the primary pathophysiological driver of the disease process.
Chronic hypoxemia from COPD causes continuous hypoxic pulmonary vasoconstriction, leading to pulmonary hypertension and subsequent right ventricular failure.
Understanding the mechanism is necessary to select a targeted, mortality-reducing intervention rather than just treating symptoms.
3
Select the intervention that addresses the root cause and improves long-term survival.
Long-term supplemental oxygen therapy reverses hypoxic pulmonary vasoconstriction.
Oxygen therapy is one of the few interventions definitively proven to decrease mortality in patients with severe resting hypoxemia (SaO2 <= 88%) due to COPD.

Key Concept

Cor pulmonale is right ventricular failure secondary to pulmonary disease. In COPD-induced cor pulmonale, continuous long-term supplemental oxygen therapy is the primary intervention proven to prolong survival by reducing hypoxic pulmonary vasoconstriction.
Rate this question

Topics

Cardiovascular System

More questions from this topic